After five of his seven siblings were diagnosed with Huntington’s disease (HD) in the past seven years, Robert Robinson and his wife, Laura, sprang to action. In an energetic quest, they became involved in the P.E.I. Chapter of Huntington Society of Canada and attended a national conference in Charlottetown last...
Latest News
Greg Perlman and his giving platform, Change Reaction, were able to raise a total of $13,500 for Harmon Jones and his family. The family of a 4-year-old boy who is recovering from cancer has a generous donor to thank for helping change their lives and get them back on their...
When Lisa Doo planned a yard sale last year to benefit research for Moyamoya disease, of which her son Justin is stricken, most folks in the Walpole area had never heard of the disease. Now, with another sale planned for Saturday, more residents are aware of Justin’s case, but Lisa...
TURKU, Finland and BOSTON, Mass. — Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, today announced that the first patient has been dosed in Phase 2 of the BEXMAB trial that evaluates the...
Houston, Texas – Rice University researchers have developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests. The advancement has the potential to improve patient outcomes, especially in rural regions with limited health care resources. Malaria remains a significant global health...
LONDON, England – Walking at a speed of 4 or more km an hour is linked to a significantly lower risk of type 2 diabetes, suggests a pooled data analysis of the available evidence, published online in the British Journal of Sports Medicine. And the faster the speed above 4...
GAINESVILLE, Fla. — University of Florida scientists have discovered why a paralyzing brain disorder speeds along more rapidly in some patients than others — a finding that may finally give researchers an entry point toward an effective treatment for amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig’s...
SAN DIEGO – Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced encouraging interim Phase 1 data from the Company’s off-the-shelf, iPSC-derived natural killer (NK) cell programs in relapsed / refractory acute myeloid leukemia (AML). The ongoing Phase...
5 of 6 Patients Achieve Objective Response, including 4 Patients with Complete Response, with Single Dose of FT596 at 900 Million Cells in Combination with Rituximab 13 of 19 Patients Achieve Objective Response with Single Dose of FT596 at 90 Million and 300 Million Cell Dose; 10 of 11 Patients...
When a doctor asks for your family medical history, he or she is not just being nosy – it can mean the difference between life and death. Just ask the Smith family of the Cotton Grove community. Tony Smith, 42, tested positive for colon cancer in February 2008. He had...